cardiovascular safety of oral alitretinoin, f. poizeau et al
Published 3 years ago • 253 plays • Length 1:46
Download video MP4
Download video MP3
Similar videos
-
5:02
safety and efficacy of amlitelimab in ad: a phase iia rct, s. weidinger et al.
-
2:25
safety, tolerability, pharmacokinetics and efficacy of hb0017, c. jiang et al.
-
4:09
impact of biologics on risk of cardiovascular events in psoriasis, w. rungapiromnan et al.
-
2:28
safety, efficacy and drug survival of biologics and biosimilars, a. egeberg et al
-
11:32
what your ana pattern means
-
9:37
ana positive - does that mean i have lupus?
-
3:31
lupus: symptoms, risk factors, pathophysiology, diagnosis and treatments.
-
0:16
5 signs of autoimmune disease #rheumatoidarthritis #lupus #psoriaticarthritis #autoimmunedisease
-
6:52
antinuclear antibodies (ana) test and their patterns | ana test | what does ana test positive mean?
-
2:21
antiinflammatory therapy and cardiovascular events
-
2:44
immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis
-
3:12
novel patient-reported outcome for paediatric localized scleroderma, c.k. zigler et al
-
19:34
eye conditions - retinal disorders: pathology review
-
1:13
patients with high cholesterol and triglycerides more prone to perioperative retinal vein occlusion
-
2:54
dr. thorsten leucker | cardiologist
-
1:15
the safety and efficacy of peritransplantation ruxolitinib in patients with mf
-
9:18
how to use oslo medical corpus - part 2
-
28:10
3: covid 19 pulmonary and cardiovascular pathology: fiorella calabrese (it)
-
55:53
there is urgent need to treat atherosclerotic cardiovascular disease
-
2:21
inactivation of angptl3 and cardiovascular disease
-
1:46
regulatory t cells as a therapeutic target in psoriasis, i.s. kotb et al.
-
3:34
choosing an anticoagulant for atrial fibrillation
Clip.africa.com - Privacy-policy